Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, 15-269 Bialystok, Poland.
Department of Dermatology and Immunodermatology, Medical University of Warsaw, 02-008 Warsaw, Poland.
Cells. 2021 Mar 15;10(3):655. doi: 10.3390/cells10030655.
With the global prevalence of type 2 diabetes mellitus steeply rising, instances of chronic, hard-healing, or non-healing diabetic wounds and ulcers are predicted to increase. The growing understanding of healing and regenerative mechanisms has elucidated critical regulators of this process, including key cellular and humoral components. Despite this, the management and successful treatment of diabetic wounds represents a significant therapeutic challenge. To this end, the development of novel therapies and biological dressings has gained increased interest. Here we review key differences between normal and chronic non-healing diabetic wounds, and elaborate on recent advances in wound healing treatments with a particular focus on biological dressings and their effect on key wound healing pathways.
随着全球 2 型糖尿病患病率的急剧上升,慢性、难以愈合或不愈合的糖尿病性伤口和溃疡的病例预计将会增加。对愈合和再生机制的深入了解阐明了这一过程的关键调节剂,包括关键的细胞和体液成分。尽管如此,糖尿病伤口的管理和成功治疗仍然是一个重大的治疗挑战。为此,新型疗法和生物敷料的开发引起了人们越来越多的兴趣。在这里,我们回顾了正常和慢性不愈合的糖尿病性伤口之间的关键差异,并详细介绍了伤口愈合治疗的最新进展,特别关注生物敷料及其对关键伤口愈合途径的影响。